Filter News
Area of Research
News Topics
- (-) Biomedical (1)
- (-) Machine Learning (1)
- (-) Mercury (1)
- (-) Transportation (4)
- 3-D Printing/Advanced Manufacturing (7)
- Artificial Intelligence (3)
- Bioenergy (5)
- Clean Water (2)
- Composites (1)
- Computer Science (7)
- Cybersecurity (2)
- Environment (4)
- Exascale Computing (1)
- Frontier (2)
- Grid (2)
- Materials Science (3)
- Neutron Science (2)
- Physics (1)
- Quantum Science (3)
- Security (2)
- Summit (3)
- Sustainable Energy (5)
Media Contacts
A technology developed at the ORNL and scaled up by Vertimass LLC to convert ethanol into fuels suitable for aviation, shipping and other heavy-duty applications can be price-competitive with conventional fuels
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
In Hong Wang’s world, nothing is beyond control. Before joining Oak Ridge National Laboratory as a senior distinguished researcher in transportation systems, he spent more than three decades studying the control of complex industrial systems in the United Kingdom.
Sometimes solutions to the biggest problems can be found in the smallest details. The work of biochemist Alex Johs at Oak Ridge National Laboratory bears this out, as he focuses on understanding protein structures and molecular interactions to resolve complex global problems like the spread of mercury pollution in waterways and the food supply.
Galigekere is principal investigator for the breakthrough work in fast, wireless charging of electric vehicles being performed at the National Transportation Research Center at Oak Ridge National Laboratory.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.